Kalkulačka z Bio Protocol na Euro
Jednoducho preveďte Bio Protocol na Euro s našou kalkulačkou. Zoznámte sa s vývojom konverzie a hlavnými ekvivalentmi medzi BIO a EUR.
Konvertor kryptomien
Bio Protocol na EUR — Trhové dáta
Trhová kapitalizácia
58,01M€
24h objem
17,77M€
Maximálna ponuka
3,32B
Ponuka v obehu
3,32B
Typ
currency
Cena BIO/EUR - Bio Protocol/Euro
Cena Bio Protocol je rastie
Hodnota Bio Protocol je 0,0273€. To znamená, že na nákup 5 BIO budeš musieť zaplatiť 0,1367€. Naopak, s 1,00€ môžeš kúpiť celkom 36,5630713 BIO, zatiaľ čo 50,00€ by ti umožnilo uskutočniť nákup 1 828,1535649 BIO.
V posledných 7 dňoch cena Bio Protocol zvýšila o +6,88%. Zatiaľ čo v posledných 24 hodinách sa cena zmenila o +6,00%.
Konverzia BIO na EUR
| Množstvo | 03. 07. 2026 22:49 |
|---|---|
| 0.5 BIO | 0,0137€ |
| 1 BIO | 0,0273€ |
| 2 BIO | 0,0547€ |
| 5 BIO | 0,1367€ |
| 10 BIO | 0,2735€ |
| 50 BIO | 1,37€ |
| 100 BIO | 2,73€ |
| 500 BIO | 13,67€ |
| 1000 BIO | 27,35€ |
Konverzia EUR na BIO
| Množstvo | 03. 07. 2026 22:49 |
|---|---|
| 0,5000€ | 0.01367500 BIO |
| 1,00€ | 0.02735000 BIO |
| 2,00€ | 0.05470000 BIO |
| 5,00€ | 0.13675000 BIO |
| 10,00€ | 0.27350000 BIO |
| 50,00€ | 1.36750000 BIO |
| 100,00€ | 2.73500000 BIO |
| 500,00€ | 13.67500000 BIO |
| 1.000,00€ | 27.35000000 BIO |
Kúpte Bio Protocol bezpečne
Zaregistrujte sa na Bit2Me a získajte prístup k najspoľahlivejšej platforme na výmenu kryptomien na bezpečné nákupy a predaje Bio Protocol.
Čo je Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
